Market Overview:
Microfluidic chips are devices that can handle and control minute amounts of fluids. The global microfluidic chips market is expected to grow from USD 1.02 billion in 2018 to USD 2.48 billion by 2030, at a CAGR of 12.8% during the forecast period. The growth of this market is mainly driven by the increasing demand for miniaturized and portable devices, technological advancements in microfluidics technology, and growing applications of microfluidics technology across various industries. However, high initial investment costs and lack of technical expertise are restraining the growth of this market to some extent. The global microfluidic chips market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into polymers, ceramics semiconductors .On the basis on application ,the market is classified into pharmaceuticals diagnostics ,drug delivery,.and others (including environmental monitoring,, food & beverage testing,.and energy harvesting).Among all regions,.However.
Product Definition:
Microfluidic chips are devices that control the flow of fluids through microscopic channels. They are used in a variety of applications, including drug delivery, diagnostics, and environmental monitoring. Microfluidic chips are important because they allow for the precise control of fluids at the microscale. This enables researchers to perform complex experiments and tests that would be difficult or impossible to carry out on a larger scale.
Polymers:
Polymers are extensively used in microfluidic chips for fabrication. They have a wide range of applications such as separation, detection, and purification of biomolecules or fluids. Polymer-based microfluidic devices find application in clinical diagnostics, drug discovery & development processes, environmental monitoring & remediation technologies among others.
Ceramics:
Ceramics is a widely used material in microfluidic chips. It can be categorized into two types: natural and synthetic. Natural ceramics are further divided into three categories including, high-temperature (up to 2,000°C), low-temperature (below 200°C), and intermediate temperature (between 200°C and 2,000°C).
Application Insights:
The drug delivery application segment dominated the global market in terms of revenue share in 2017. This is attributed to increasing R&D activities for developing novel microfluidic chips for drug delivery applications. For instance, a research study was conducted by scientists at the University of Delaware and their results were published in Lab on a Chip (Lonza). The study focused on designing an optically triggered micropump that can be used for rapid, high-density and parallel processing of DNA vaccines. Such initiatives are expected to drive product demand over the forecast period.
Microfluidic chips have numerous applications across various end-use industries including diagnostics, pharmaceuticals and food & beverage which are further categorized into point-of-care testing, laboratory analysis as well as production systems based on their usage scenario.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high research and development activities undertaken by major pharmaceutical and biotechnology companies for commercializing products at a relatively lower price. In addition, increasing R&D spending by various government agencies in this region is also one of the key factors responsible for regional growth.
Asia Pacific microfluidic chip market is anticipated to grow at a lucrative rate over the forecast period due to rising healthcare expenditure, growing population, and improving living standards leading to increased demand for diagnostic services resulting in an increase in disease prevalence which will drive product adoption across several industries including pharmaceuticals & biotechnology and food & beverage in this region.
Growth Factors:
- Increasing demand for miniaturization in the electronics industry is expected to drive the growth of microfluidic chips market.
- Rising prevalence of chronic diseases and increasing demand for point-of-care diagnostics is also anticipated to boost the growth of microfluidic chips market over the forecast period.
- Growing number of research and development activities in life sciences sector is projected to fuel the demand for microfluidic chips over the next few years.
- Increasing application areas of microfluidics technology such as drug discovery, biomarker detection, and tissue engineering are estimated to create new opportunities for this market in near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Microfluidic Chips Market Research Report
By Type
Polymers, Ceramics, Semi-conductors
By Application
Pharmaceutical, Diagnostic, Drug Deliver
By Companies
Agilent, Fluidigm Corporation, Micralyne, Inc, Becton Dickinson, Danaher, PerkinElmer, Bio-Rad Laboratories, Dolomite, 908 Devices, MicroLIQUID, MicruX Technologies, Micronit, Fluigent
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Microfluidic Chips Market Report Segments:
The global Microfluidic Chips market is segmented on the basis of:
Types
Polymers, Ceramics, Semi-conductors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical, Diagnostic, Drug Deliver
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent
- Fluidigm Corporation
- Micralyne, Inc
- Becton Dickinson
- Danaher
- PerkinElmer
- Bio-Rad Laboratories
- Dolomite
- 908 Devices
- MicroLIQUID
- MicruX Technologies
- Micronit
- Fluigent
Highlights of The Microfluidic Chips Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymers
- Ceramics
- Semi-conductors
- By Application:
- Pharmaceutical
- Diagnostic
- Drug Deliver
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microfluidic Chips Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microfluidic chips are a type of electronic chip that can be used to process small amounts of fluid at high speeds. They are often used in medical devices and research labs, as they allow for more precise and efficient processing than traditional methods.
Some of the key players operating in the microfluidic chips market are Agilent, Fluidigm Corporation, Micralyne, Inc, Becton Dickinson, Danaher, PerkinElmer, Bio-Rad Laboratories, Dolomite, 908 Devices, MicroLIQUID, MicruX Technologies, Micronit, Fluigent.
The microfluidic chips market is expected to grow at a compound annual growth rate of 12.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Microfluidic Chips Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Microfluidic Chips Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Microfluidic Chips Market - Supply Chain
4.5. Global Microfluidic Chips Market Forecast
4.5.1. Microfluidic Chips Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Microfluidic Chips Market Size (000 Units) and Y-o-Y Growth
4.5.3. Microfluidic Chips Market Absolute $ Opportunity
5. Global Microfluidic Chips Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Microfluidic Chips Market Size and Volume Forecast by Type
5.3.1. Polymers
5.3.2. Ceramics
5.3.3. Semi-conductors
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Microfluidic Chips Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Microfluidic Chips Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical
6.3.2. Diagnostic
6.3.3. Drug Deliver
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Microfluidic Chips Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Microfluidic Chips Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Microfluidic Chips Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Microfluidic Chips Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Microfluidic Chips Demand Share Forecast, 2019-2026
9. North America Microfluidic Chips Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Microfluidic Chips Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Microfluidic Chips Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical
9.4.2. Diagnostic
9.4.3. Drug Deliver
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Microfluidic Chips Market Size and Volume Forecast by Type
9.7.1. Polymers
9.7.2. Ceramics
9.7.3. Semi-conductors
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Microfluidic Chips Demand Share Forecast, 2019-2026
10. Latin America Microfluidic Chips Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Microfluidic Chips Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Microfluidic Chips Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical
10.4.2. Diagnostic
10.4.3. Drug Deliver
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Microfluidic Chips Market Size and Volume Forecast by Type
10.7.1. Polymers
10.7.2. Ceramics
10.7.3. Semi-conductors
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Microfluidic Chips Demand Share Forecast, 2019-2026
11. Europe Microfluidic Chips Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Microfluidic Chips Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Microfluidic Chips Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical
11.4.2. Diagnostic
11.4.3. Drug Deliver
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Microfluidic Chips Market Size and Volume Forecast by Type
11.7.1. Polymers
11.7.2. Ceramics
11.7.3. Semi-conductors
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Microfluidic Chips Demand Share, 2019-2026
12. Asia Pacific Microfluidic Chips Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Microfluidic Chips Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Microfluidic Chips Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical
12.4.2. Diagnostic
12.4.3. Drug Deliver
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Microfluidic Chips Market Size and Volume Forecast by Type
12.7.1. Polymers
12.7.2. Ceramics
12.7.3. Semi-conductors
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Microfluidic Chips Demand Share, 2019-2026
13. Middle East & Africa Microfluidic Chips Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Microfluidic Chips Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Microfluidic Chips Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical
13.4.2. Diagnostic
13.4.3. Drug Deliver
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Microfluidic Chips Market Size and Volume Forecast by Type
13.7.1. Polymers
13.7.2. Ceramics
13.7.3. Semi-conductors
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Microfluidic Chips Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Microfluidic Chips Market: Market Share Analysis
14.2. Microfluidic Chips Distributors and Customers
14.3. Microfluidic Chips Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agilent
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Fluidigm Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Micralyne, Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Becton Dickinson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Danaher
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PerkinElmer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bio-Rad Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Dolomite
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. 908 Devices
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. MicroLIQUID
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. MicruX Technologies
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Micronit
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Fluigent
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
